Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
Feature|Videos|January 9, 2025

Final Thoughts and Looking Forward: The Future of Pandemic Preparedness

Sustained investment, technological innovation, and collaboration are essential to future pandemic preparedness.

The panel concludes with calls for sustained investment in pandemic readiness. They emphasize leveraging AI and biotech advancements, maintaining global collaboration, and fostering public trust to ensure a robust response to future health crises.


Related to this article

The BioPharm Brief: A First for Streamlined Biosimilar Approval, a Head-to-Head Bispecific Trial in Wet AMD, and In Vivo KIR-CAR T
Biocon’s pertuzumab biosimilar Pebrilzo becomes the first biosimilar approved under EMA’s tailored clinical approach, Visara doses the first patient in a phase 2b trial comparing its VEGF-A/ANG-2 bispecific VIS-101 with aflibercept in wet AMD, and Verismo Therapeutics licenses Stanford’s PACK-IT technology for in vivo KIR-CAR T therapies.